To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why
As the adoption of GLP-1 receptor agonist obesity medications such as Wegovy and Mounjaro accelerates, medical experts are calling for structured...
Search results for "active ingredient"
Endocrinologist Woo Chang-yoon Touts ‘Natural Wegovy’ Egg and Olive Oil Combo to Tame Cravings
Woo Chang-yoon, an endocrinologist who has emerged as a prominent voice behind the “natural Wegovy” diet trend, has explained the scientific...
Beyond Cosmetics: Foreign Tourists Stock Up on Korean OTC Skin Ointments
Search TikTok for "must-buy items at Korean pharmacies," and a steady stream of video recommendations fills the screen.
Yuhan Corp. Launches Drinkable Joint Supplement 'Yuhan Chondroitin 1200'
Yuhan Corp. announced on Aug. 31 that it will launch "Yuhan Chondroitin 1200," a liquid joint and cartilage health...
Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group
Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of...
‘I Eat Bread Like Crazy’: How K-Pop Star Mimi Stays at 47 kg Through High Daily Activity
Oh My Girl member Mimi, 31, recently shared how she maintains her slim physique despite an intense love for bakery...
3 K-Beauty Products That Deliver on Ingredients and Price
Skin changes with the seasons. As temperature and humidity shift, skin can feel tight, develop flaky patches, or react...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009
Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs
SK Plasma announced on Sept. 1 that it has begun distributing Revolpag Tablets 75 mg in South Korea, expanding its...
Zymfentra U.S. Sales Surge 176% as Celltrion’s Remsima Franchise Eyes 1 Trillion Won Annual Revenue
Biopharmaceutical company Celltrion announced on Aug. 27 that combined first-half sales of its subcutaneous infliximab...